查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1697980

控釋藥物輸送市場－全球產業規模、佔有率、趨勢、機會及預測（按技術、釋放機制、應用、地區和競爭細分，2020-2030 年）

Controlled Release Drug Delivery Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Technology, By Release Mechanism, By Application, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 186 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球控釋藥物輸送市場價值為 562.4 億美元，預計到 2030 年將達到 1,037.5 億美元，複合年成長率為 10.72%。隨著製藥公司越來越注重提高藥物療效和患者依從性，控釋藥物輸送市場正在不斷擴大。該系統能夠在較長時間內逐漸釋放藥物，從而減少服藥頻率並最大限度地減少副作用。由於對精準醫療和改善治療效果的持續藥物配方的需求不斷成長，市場正在經歷強勁成長。主要參與者正在投資先進的聚合物技術、基於奈米技術的輸送系統和可生物分解的植入物，以最佳化藥物釋放機制。由於控釋製劑可以提高治療順從性，心血管疾病、糖尿病和神經系統疾病等慢性疾病的盛行率不斷上升，進一步推動了其應用。

市場概覽
預測期 2026-2030
2024 年市場規模 562.4億美元
2030年市場規模 1037.5億美元
2025-2030 年複合年成長率 10.72％
成長最快的領域 定向投放
最大的市場 北美洲

市場受益於藥物配方和輸送系統的技術進步，從而實現更有效率、更有針對性的治療。微球、脂質體和經皮貼片的創新正在提高藥物的生物利用度和穩定性。製藥公司正在積極尋求策略合作，以加速控釋製劑的開發，特別是針對複雜的生物製劑和基因療法。醫療保健支出的增加和對新型藥物輸送方法的有利監管支持正在促進市場擴張。以患者為中心的解決方案的需求正在塑造行業趨勢，口服、注射和植入式藥物輸送系統已被廣泛認可。生物製藥和個人化醫療的激增帶來了豐厚的機遇，鼓勵了先進藥物封裝技術的進一步研究和開發。

主要市場促進因素

慢性病盛行率不斷上升

主要市場挑戰

監管障礙和批准延遲

主要市場趨勢

可生物分解和可植入藥物傳輸系統

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第 4 章：顧客之聲

第5章：全球控釋藥物輸送市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 依技術分類（Wurster 技術、凝聚法、微膠囊化、植入物、經皮貼片、標靶遞送、其他）
    • 依釋放機制分類（聚合物基系統、微儲庫分區控制藥物傳輸系統、回饋調節藥物傳遞系統、活化調節藥物傳遞系統、化學活化）
    • 依應用（定量吸入器、注射、經皮貼片和眼部貼片、輸液幫浦、口服控藥系統、藥物洗脫支架）
    • 按地區
    • 按公司分類（2024）
  • 市場地圖

第6章：北美控釋藥物輸送市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 加拿大
    • 墨西哥

第 7 章：歐洲控釋藥物輸送市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 英國
    • 義大利
    • 法國
    • 西班牙

第 8 章：亞太地區控釋藥物輸送市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區：國家分析
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：南美洲控釋藥物輸送市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 阿根廷
    • 哥倫比亞

第10章：中東和非洲控釋藥物輸送市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章：市場動態

  • 促進因素與挑戰

第 12 章：市場趨勢與發展

  • 最新動態
  • 產品發布
  • 合併與收購

第 13 章：全球控釋藥物輸送市場：SWOT 分析

第 14 章：競爭格局

  • Orbis Biosciences, Inc.
  • Merck and Co., Inc.
  • Alkermes plc
  • Johnson and Johnson
  • Coating Place, Inc.
  • Corium International, Inc.
  • Depomed, Inc.
  • Pfizer, Inc
  • Aradigm Corporation
  • Capsugel Inc

第 15 章：策略建議

第16章調查會社について,免責事項

簡介目錄
Product Code: 17468

Global Controlled Release Drug Delivery Market was valued at USD 56.24 Billion in 2024 and is expected to reach USD 103.75 Billion in the forecast period with a CAGR of 10.72% through 2030. The controlled release drug delivery market is expanding as pharmaceutical companies increasingly focus on enhancing drug efficacy and patient compliance. This system enables the gradual release of drugs over an extended period, reducing dosing frequency and minimizing side effects. The market is witnessing strong growth due to rising demand for precision medicine and sustained drug formulations that improve therapeutic outcomes. Key players are investing in advanced polymer technologies, nanotechnology-based delivery systems, and biodegradable implants to optimize drug release mechanisms. The increasing prevalence of chronic diseases such as cardiovascular disorders, diabetes, and neurological conditions is further driving adoption, as controlled release formulations offer improved treatment adherence.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 56.24 Billion
Market Size 2030USD 103.75 Billion
CAGR 2025-203010.72%
Fastest Growing SegmentTargeted Delivery
Largest MarketNorth America

The market benefits from technological advancements in drug formulation and delivery systems, enabling more efficient and targeted therapies. Innovations in microspheres, liposomes, and transdermal patches are enhancing drug bioavailability and stability. Pharmaceutical companies are actively seeking strategic collaborations to accelerate the development of controlled release formulations, particularly for complex biologics and gene therapies. Rising healthcare expenditure and favorable regulatory support for novel drug delivery methods are fostering market expansion. Demand for patient-centric solutions is shaping industry trends, with oral, injectable, and implantable drug delivery systems gaining widespread acceptance. The surge in biopharmaceuticals and personalized medicine presents lucrative opportunities, encouraging further research and development in advanced drug encapsulation techniques.

Key Market Drivers

Increasing Prevalence of Chronic Diseases

The global incidence of chronic diseases such as diabetes, cardiovascular diseases, cancer, and respiratory disorders continues to rise. According to the World Health Organization (WHO), cardiovascular diseases accounted for approximately 19 million deaths in 2021, cancers for 10 million, chronic respiratory diseases for 4 million, and diabetes for over 2 million, including deaths from kidney disease caused by diabetes. This increase is largely attributed to factors such as sedentary lifestyles, poor dietary habits, and an aging population. Notably, the number of people living with diabetes surged from 200 million in 1990 to 830 million in 2022, with prevalence rising more rapidly in low- and middle-income countries.

Managing chronic diseases often necessitates long-term medication regimens, which can be challenging for patients to adhere to consistently. Studies have shown that approximately 50% of patients with chronic conditions demonstrate poor medication adherence, leading to suboptimal health outcomes and increased healthcare costs.

Key Market Challenges

Regulatory Hurdles and Approval Delays

Stringent Regulatory Requirements: Developing and gaining regulatory approval for controlled release drug delivery systems involves navigating complex and stringent regulatory pathways. Regulatory agencies, such as the FDA (U.S. Food and Drug Administration) and the EMA (European Medicines Agency), have rigorous requirements to ensure the safety and efficacy of these systems.

The regulatory approval process can be lengthy and resource-intensive, significantly delaying the market entry of new controlled release products. This can discourage investment and slow down market growth. Regulatory requirements and guidelines for drug delivery systems may evolve over time, necessitating costly adjustments to meet updated standards.

Key Market Trends

Biodegradable and Implantable Drug Delivery Systems

Growing environmental awareness and sustainability concerns have prompted the development of biodegradable drug delivery systems. These systems are designed to gradually release drugs while breaking down harmlessly in the body, reducing waste and environmental impact.

Implantable controlled release systems, such as biodegradable implants, are gaining prominence for delivering long-lasting therapeutics. They offer convenience for patients by eliminating the need for frequent dosing and provide sustained drug release over extended periods. Biodegradable and implantable systems are particularly valuable in treating chronic conditions, as they can provide continuous drug delivery, potentially improving patient compliance and therapeutic outcomes.

Key Market Players

  • Orbis Biosciences, Inc.
  • Merck and Co., Inc.
  • Alkermes plc
  • Johnson and Johnson
  • Coating Place, Inc.
  • Corium International, Inc.
  • Depomed, Inc.
  • Pfizer, Inc
  • Aradigm Corporation
  • Capsugel Inc

Report Scope:

In this report, the Global Controlled Release Drug Delivery Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Controlled Release Drug Delivery Market, By Technology:

  • Wurster Technique
  • Coacervation
  • Micro Encapsulation
  • Implants
  • Transdermal
  • Targeted Delivery
  • Others

Controlled Release Drug Delivery Market, By Release Mechanism:

  • Polymer Based Systems
  • Micro Reservoir Partition Controlled Drug Delivery Systems
  • Feedback Regulated Drug Delivery Systems
  • Activation-modulated Drug Delivery Systems
  • Chemically Activated

Controlled Release Drug Delivery Market, By Application:

  • Metered Dose Inhalers
  • Injectable
  • Transdermal and Ocular Patches
  • Infusion Pumps
  • Oral Controlled-drug delivery Systems
  • Drug Eluting Stents

Controlled Release Drug Delivery Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Controlled Release Drug Delivery Market.

Available Customizations:

Global Controlled Release Drug Delivery market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Applications
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Controlled Release Drug Delivery Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Technology (Wurster Technique, Coacervation, Micro Encapsulation, Implants, Transdermal, Targeted Delivery, Others)
    • 5.2.2. By Release Mechanism (Polymer Based Systems, Micro Reservoir Partition Controlled Drug Delivery Systems, Feedback Regulated Drug Delivery Systems, Activation-modulated Drug Delivery Systems, Chemically Activated)
    • 5.2.3. By Application (Metered Dose Inhalers, Injectable, Transdermal and Ocular Patches, Infusion Pumps, Oral Controlled-drug delivery Systems, Drug Eluting Stents)
    • 5.2.4. By Region
    • 5.2.5. By Company (2024)
  • 5.3. Market Map

6. North America Controlled Release Drug Delivery Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Technology
    • 6.2.2. By Release Mechanism
    • 6.2.3. By Application
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Controlled Release Drug Delivery Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Technology
        • 6.3.1.2.2. By Release Mechanism
        • 6.3.1.2.3. By Application
    • 6.3.2. Canada Controlled Release Drug Delivery Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Technology
        • 6.3.2.2.2. By Release Mechanism
        • 6.3.2.2.3. By Application
    • 6.3.3. Mexico Controlled Release Drug Delivery Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Technology
        • 6.3.3.2.2. By Release Mechanism
        • 6.3.3.2.3. By Application

7. Europe Controlled Release Drug Delivery Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Technology
    • 7.2.2. By Release Mechanism
    • 7.2.3. By Application
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Controlled Release Drug Delivery Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Technology
        • 7.3.1.2.2. By Release Mechanism
        • 7.3.1.2.3. By Application
    • 7.3.2. United Kingdom Controlled Release Drug Delivery Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Technology
        • 7.3.2.2.2. By Release Mechanism
        • 7.3.2.2.3. By Application
    • 7.3.3. Italy Controlled Release Drug Delivery Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecasty
        • 7.3.3.2.1. By Technology
        • 7.3.3.2.2. By Release Mechanism
        • 7.3.3.2.3. By Application
    • 7.3.4. France Controlled Release Drug Delivery Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Technology
        • 7.3.4.2.2. By Release Mechanism
        • 7.3.4.2.3. By Application
    • 7.3.5. Spain Controlled Release Drug Delivery Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Technology
        • 7.3.5.2.2. By Release Mechanism
        • 7.3.5.2.3. By Application

8. Asia-Pacific Controlled Release Drug Delivery Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Technology
    • 8.2.2. By Release Mechanism
    • 8.2.3. By Application
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Controlled Release Drug Delivery Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Technology
        • 8.3.1.2.2. By Release Mechanism
        • 8.3.1.2.3. By Application
    • 8.3.2. India Controlled Release Drug Delivery Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Technology
        • 8.3.2.2.2. By Release Mechanism
        • 8.3.2.2.3. By Application
    • 8.3.3. Japan Controlled Release Drug Delivery Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Technology
        • 8.3.3.2.2. By Release Mechanism
        • 8.3.3.2.3. By Application
    • 8.3.4. South Korea Controlled Release Drug Delivery Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Technology
        • 8.3.4.2.2. By Release Mechanism
        • 8.3.4.2.3. By Application
    • 8.3.5. Australia Controlled Release Drug Delivery Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Technology
        • 8.3.5.2.2. By Release Mechanism
        • 8.3.5.2.3. By Application

9. South America Controlled Release Drug Delivery Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Technology
    • 9.2.2. By Release Mechanism
    • 9.2.3. By Application
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Controlled Release Drug Delivery Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Technology
        • 9.3.1.2.2. By Release Mechanism
        • 9.3.1.2.3. By Application
    • 9.3.2. Argentina Controlled Release Drug Delivery Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Technology
        • 9.3.2.2.2. By Release Mechanism
        • 9.3.2.2.3. By Application
    • 9.3.3. Colombia Controlled Release Drug Delivery Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Technology
        • 9.3.3.2.2. By Release Mechanism
        • 9.3.3.2.3. By Application

10. Middle East and Africa Controlled Release Drug Delivery Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Technology
    • 10.2.2. By Release Mechanism
    • 10.2.3. By Application
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Controlled Release Drug Delivery Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Technology
        • 10.3.1.2.2. By Release Mechanism
        • 10.3.1.2.3. By Application
    • 10.3.2. Saudi Arabia Controlled Release Drug Delivery Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Technology
        • 10.3.2.2.2. By Release Mechanism
        • 10.3.2.2.3. By Application
    • 10.3.3. UAE Controlled Release Drug Delivery Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Technology
        • 10.3.3.2.2. By Release Mechanism
        • 10.3.3.2.3. By Application

11. Market Dynamics

  • 11.1. Drivers & Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Product Launches
  • 12.3. Mergers & Acquisitions

13. Global Controlled Release Drug Delivery Market: SWOT Analysis

14. Competitive Landscape

  • 14.1. Orbis Biosciences, Inc.
  • 14.2. Merck and Co., Inc.
  • 14.3. Alkermes plc
  • 14.4. Johnson and Johnson
  • 14.5. Coating Place, Inc.
  • 14.6. Corium International, Inc.
  • 14.7. Depomed, Inc.
  • 14.8. Pfizer, Inc
  • 14.9. Aradigm Corporation
  • 14.10.Capsugel Inc

15. Strategic Recommendations

16. About Us & Disclaimer